Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/14274
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Aleksandar Tepavac | en_US |
dc.contributor.author | Nevena Sečen | en_US |
dc.contributor.author | Danica Sazdanić Velikić | en_US |
dc.contributor.author | Gordana Popović | en_US |
dc.contributor.author | Branislav Perin | en_US |
dc.date.accessioned | 2020-03-03T14:55:35Z | - |
dc.date.available | 2020-03-03T14:55:35Z | - |
dc.date.issued | 2010-10-01 | - |
dc.identifier.issn | 11070625 | en_US |
dc.identifier.uri | https://open.uns.ac.rs/handle/123456789/14274 | - |
dc.description.abstract | Purpose: The aim of this study was to evaluate the influence of atelectasis (AT) on overall survival of patients with non small cell lung cancer (NSCLC). Methods: The study included patients of both sexes with unresectable stage III and IV NSCLC with good performance status (PS) (ECOG <2). Patients were divided into two groups: with AT (AT+) and without AT (AT-): Factors analyzed included sex, age, histologic type, ECOG performance status, stage of disease and treatment modality. Overall survival was estimated according to Kaplan-Meier method, and multivariate analysis was used to identify independent prognostic factors. Results: We evaluated 247 patients (83% males and 17% females); 47/247 (19%) of patients belonged to AT+ group. In this group 21% of patients had stage IIIA, 46% IIIB stage, and 33% IV stage. Overall survival was significantly longer in the AT+ group (15.23 vs. 9.03 months, p=0.001). AT+ patients in stages III and IV had significantly longer overall survival than AT-patients in the same stages (p=0.001, p=0.002, respectively). Multivariate analysis showed that atelectasis (p=0.001), stage of disease (p=0.001), and treatment modality (p=0.005) were independent prognostic factors associated with survival. Conclusion: Atelectasis is favorable prognostic factor concerning overall survival in patients with NSCLC. © 2010 Zerbinis Medical Publications. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Journal of B.U.ON. | en_US |
dc.subject | atelectasis | en_US |
dc.subject | non small cell lung cancer (NSCLC) | en_US |
dc.subject | survival | en_US |
dc.title | Atelectasis: Positive or negative prognostic factor on outcome of patients with non-small cell lung cancer? | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.pmid | 15 | - |
dc.identifier.scopus | 2-s2.0-78651397856 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/78651397856 | - |
dc.description.version | Published | en_US |
dc.relation.lastpage | 683 | en_US |
dc.relation.firstpage | 679 | en_US |
dc.relation.issue | 4 | en_US |
dc.relation.volume | 15 | en_US |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
crisitem.author.dept | Medicinski fakultet, Katedra za internu medicinu | - |
crisitem.author.dept | Medicinski fakultet, Katedra za gerijatriju | - |
crisitem.author.parentorg | Medicinski fakultet | - |
crisitem.author.parentorg | Medicinski fakultet | - |
Appears in Collections: | MDF Publikacije/Publications |
SCOPUSTM
Citations
2
checked on Nov 20, 2023
Page view(s)
44
Last Week
14
14
Last month
8
8
checked on May 10, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.